AMRI (NASDAQ: AMRI) will report second quarter results before the opening of the market on Wednesday, August 6, 2008. The company will hold a conference call at 10 a.m. EDT to discuss its quarterly financial results.
To listen to the conference call, dial 888-221-9576 (for domestic calls) or 913-312-0391 (for international calls) at 9:45 a.m. EDT and provide conference code 4082753. In addition, the call is being webcast on the Internet and can be accessed on the company’s website at www.amriglobal.com.
Replays of the call will be available for seven days following the call beginning at noon EDT on August 6, 2008. To access the replay by telephone, call 888-203-1112 (for domestic calls) or 719-457-0820 (for international calls) and use passcode 4082753. In addition, replays of the call will be available as a webcast for three months in the investor area of the company’s website at www.amriglobal.com/investor_relations/.
Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world’s leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.
Albany Molecular Research, Inc.
Andrea Schulz, 518-512-2226
AMRI Corporate Communications
Peter Jerome, 518-512-2220
AMRI Director of Investor Relations